Integrated exposure-response analysis of efficacy and safety of lurbinectedin to support the dose regimen in small-cell lung cancer.
Carlos Fernández-TeruelSalvador FudioRubin LubomirovPublished in: Cancer chemotherapy and pharmacology (2021)
Clinicaltrials.gov: NCT02454972; registered May 27, 2015.
Keyphrases